Autologous Platelet-Rich Plasma Therapy: A Promising Method for Tissue Repair and Regeneration in Many Medical Fields

The document from October 5, 2020, discussed the use of platelet-rich plasma (PRP) therapy in various medical fields. PRP, prepared from autologous blood, contains growth factors that stimulate tissue regeneration. The therapy is considered promising for treating tissue injuries due to its biological nature and the low risk of infection. However, the authors noted that there were wide variations in PRP definitions, preparation protocols, and application methods, making it difficult to compare and confirm the therapy's efficacy. They emphasized the urgent need for standardizing these protocols and methods. Despite its potential, the lack of standardization raised numerous questions and controversies about PRP therapy.